Livestock News

New research to develop African swine fever diagnostic test

Published:

Since last fall, African swine fever has disrupted the swine industry in Asia. In order to combat the disease, Boehringer Ingelheim and GNA Biosolutions announce that they have entered into a research collaboration focused on the development of a rapid African swine fever diagnostic test. The test would be used in combination with GNA’s portable molecular diagnostic platform, and is aimed at supporting the fight against the worldwide spread of this deadly disease.

ASF is a devastating viral infection of swine causing severe clinical disease and high mortality. The disease cannot be treated and currently no effective vaccines are available. African swine fever does not affect humans.

It is currently unclear how far ASF will spread, jeopardizing many countries’ pig trade and supplies. Due to ASF outbreaks, more than 600,000 pigs were culled within the past few months in China alone.

“We are delighted to enter this collaboration with Boehringer Ingelheim, a global leader in animal health. This collaboration further emphasises the role of GNA Biosolutions in the rapidly developing field of extra-laboratory diagnostics and extends the application of our Pulse Controlled Amplification (PCA) technology into animal protection,” said GNA Biosolutions co-founder and Managing Director, Dr. Lars Ullerich.

“Together with GNA we are striving to develop holistic solutions for veterinarians, farmers and the food producing industry. The targeted platform will allow for faster decision making based on more comprehensive diagnostic data,” shared the Global Head of Diagnostics & Monitoring Animal Health at Boehringer Ingelheim, Rolf-Dieter Günther.

Any views or opinions expressed in this article are those of the author and do not reflect those of AGDAILY. Comments on this article reflect the sole opinions of their writers.
Previous Article Next Page